PATENT CLAIM ANALYSIS

Application Number: 15747157
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "054000"]

Abstract:
Disclosed are ophthalmic formulations which use complexes called L/H-HA, obtainable by subjecting at least two fractions of hyaluronic acids and/or other glycosaminoglycans with different molecular weights to an appropriate heat cycle.

Claim (Index 1):
Ophthalmic formulations comprising as active ingredients cooperative hybrid complexes named L/H-HA, obtainable by heating at 100-130\u00b0 C. for 10-30 min a mixture of an aqueous solution of at least one fraction (L-HA) of hyaluronic acid or of chondroitin sulphate, keratan sulphate or chondroitin (CS, KS, C), said fraction having an average molecular weight ranging from 1\u00b7104 to 5\u00b7105 Da, and of an aqueous solution of at least one fraction (H-HA) of hyaluronic acid having an average molecular weight at least 5 times higher than that of L-HA and in any event ranging from 5\u00b7104 Da to 5\u00b7106 Da, the weight ratio of L-HA to H-HA in the L/H-HA complex ranging from 0.5 to 2.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14974657', '10484241', '12063623', '12681256', '13147153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7278210813122122
- 35 USC 102 Novelty (BERT): 0.4900427350989921
- Combined Prediction Score: 0.7040432466908902
- Mean Citation Score: 156.149132
- Max Citation Score: 179.60078
- Similarity Product: 118.63016720620274

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test